Get started
Author

M.P. López-Cabrerizo

Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer
1999 · Felipe Cardenal, M. Paz López-Cabrerizo, et al. · Journal of Clinical Oncology · 471
Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients
1998 · M. Sánchez-Céspedes, M. Monzó, et al. · Annals of Oncology · 93
PDF
Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors
1997 · Rafael Rosell, Alex Pifarré, et al. · International Journal of Cancer · 65
PDF
Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
1997 · M Sánchez-Céspedes, R Rosell, et al. · PubMed · 27
Preoperative chemotherapy for stage MIA non-small cell lung cancer
1997 · Rafael Rosell, Maria Paz López-Cabrerizo, et al. · Current Opinion in Oncology · 23
Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trials.
1998 · E Felip, B Massuti, et al. · PubMed · 14
243 Spanish lung cancer group randomized trial of preoperative chemotherapy (cisplatin either 50 mg/m2 or 100 mg/m2) in stage IIIA (N2) non-small cell lung cancer (NSCLC)
1997 · E. Felip, I. Moreno, et al. · Lung Cancer · 8
A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancer.
1997 · R Rosell, E Felip, et al. · PubMed · 6
Genetic susceptibility linked with rare HA-ras1 alleles and microsatellite alterations in non-small cell lung cancer (NSCLC)
1997 · R. Rosell, A. Pifarré, et al. · European Journal of Cancer
35 A sequence-dependent paclitaxel-etoposide phase II trial in patients with non-small cell lung cancer (NSCLC)
1997 · B. Massuti, E. Felip, et al. · Lung Cancer
Works count: 10
Citation count: 707
H-index: 7
I10-index: 6
Year
Topic
Type